Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
1,4-Anhydro-1,5-dihydroxy-1-methoxyempagliflozin is an impurity of Empagliflozin (E521510) which is a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats.
?您的位置：
